With recognition of the various CLAD phenotypes , further refinements of these diagnostic criteria will allow for an improved ability to identify and characterize patients who develop or are at risk for BOS , prognosticate outcomes , and , most importantly , marshal in future strategies directed at treating and preventing chronic lung dysfunction after lung transplantation .